PATENT CLAIM ANALYSIS

Application Number: 15963599
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-04
Patent Classification: ["514", "575000"]

Abstract:
The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.

Claim (Index 23):
The conjugate of  claim 16 , wherein the target molecule is a peptide.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.06667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15518333', '13395346', '14645967', '13884660', '13521177']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7844665159537846
- 35 USC 102 Novelty (BERT): 0.5850808717743625
- Combined Prediction Score: 0.7645279515358424
- Mean Citation Score: 311.209826
- Max Citation Score: 624.70917
- Similarity Product: 373.29677340761305

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test